Gold Coast标准在肌萎缩侧索硬化中的诊断效用
该研究回顾性分析506例患者,比较Gold Coast标准与Awaji及修订版El Escorial标准对肌萎缩侧索硬化的诊断准确性。Gold Coast标准敏感性与后两者相当,且在延髓和肢体起病及非典型表型中表现更优,建议用于临床实践和治疗试验。
要点
- Gold Coast标准诊断ALS的敏感性为92%,与Awaji和rEEC标准相当。
- Gold Coast标准在延髓起病、肢体起病及非典型表型中敏感性维持良好。
- 临床实践和治疗试验中应考虑采用Gold Coast标准。
核心结论
- Gold Coast标准在ALS诊断中具有良好诊断效用,敏感性与Awaji和rEEC标准相当。
研究设计与样本
- 回顾性纳入506例患者(302例男性,204例女性),比较Gold Coast标准与Awaji及rEEC标准的诊断准确性。
主要发现
- Gold Coast标准敏感性为92%(95%CI=88.7-94.6%),Awaji为90.3%(95%CI=86.69-93.2%),rEEC为88.6%(95%CI=84.8-91.7%)。
- Gold Coast标准在不同起病部位、病程和功能残疾亚组中敏感性维持。
- 在非典型ALS表型中,Gold Coast标准表现出更高的敏感性和特异性。
关键数值与推荐
- Gold Coast标准敏感性92%(95%CI=88.7-94.6%),Awaji标准90.3%(95%CI=86.69-93.2%),rEEC标准88.6%(95%CI=84.8-91.7%)。
临床怎么用
- Gold Coast标准可用于ALS临床诊断,尤其在延髓起病、肢体起病及非典型表型患者中。
- Gold Coast标准应被考虑用于临床实践和治疗试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The diagnosis of amyotrophic lateral sclerosis (ALS) remains problematic, with current diagnostic criteria (revised El Escorial [rEEC] and Awaji) being complex and prone to error. Consequently, the diagnostic utility of the recently proposed Gold Coast criteria was determined in ALS. METHODS: We retrospectively reviewed 506 patients (302 males, 204 females) to compare the diagnostic accuracy of the Gold Coast criteria to that of the Awaji and rEEC criteria (defined by the proportion of patients categorized as definite, probable, or possible ALS) in accordance with standards of reporting of diagnostic accuracy criteria. RESULTS: The sensitivity of Gold Coast criteria (92%, 95% confidence interval [CI] = 88.7-94.6%) was comparable to that of Awaji (90.3%, 95% CI = 86.69-93.2%) and rEEC (88.6, 95% CI = 84.8-91.7%) criteria. Additionally, the Gold Coast criteria sensitivity was maintained across different subgroups, defined by site of onset, disease duration, and functional disability. In atypical ALS phenotypes, the Gold Coast criteria exhibited greater sensitivity and specificity. INTERPRETATION: The present study established the diagnostic utility of the Gold Coast criteria in ALS, with benefits evident in bulbar and limb onset disease patients, as well as atypical phenotypes. The Gold Coast criteria should be considered in clinical practice and therapeutic trials. ANN NEUROL 2021;89:979-986.
引用
- Hannaford A, Pavey N, van den Bos M, et al. Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis. Ann Neurol. 2021. PMID: 33565111. doi:10.1002/ana.26045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。